CHRONIC INDUCIBLE URTICARIA
Clinical trials for CHRONIC INDUCIBLE URTICARIA explained in plain language.
Never miss a new study
Get alerted when new CHRONIC INDUCIBLE URTICARIA trials appear
Sign up with your email to follow new studies for CHRONIC INDUCIBLE URTICARIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill could tame stubborn hives that antihistamines Can't stop
Disease control OngoingThis study tests an experimental drug called BLU-808 for people with chronic hives (urticaria) that don't get better with standard antihistamines. The drug works by blocking a protein called KIT, which may help control the allergic reaction causing the hives. About 105 adults wil…
Matched conditions: CHRONIC INDUCIBLE URTICARIA
Phase: PHASE2 • Sponsor: Blueprint Medicines Corporation • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New hope for chronic hives sufferers: drug targets root cause
Disease control OngoingThis study tests a new medication, remibrutinib, for people with chronic hives caused by triggers like cold, heat, or scratching (chronic inducible urticaria). The drug aims to control symptoms better than standard antihistamines. About 362 adults will take the drug or a placebo …
Matched conditions: CHRONIC INDUCIBLE URTICARIA
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC